Skip to main content
SpringerLink
Log in

Apoptosis and Antiphospholipid Antibodies

  • Chapter
Hughes Syndrome

  • 734 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Lafer E, Rauch J, Andrzejewski C, et al. Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids. J Exp Med 1981;153:897–904.

    Article  PubMed  CAS  Google Scholar 

  2. Boey ML, Gharavi AE, Elkon KB, Loizou S, Hughes GRV. Thrombosis in SLE, striking association with the presence of circulating “lupus anticoagulant”. Br Med J 1983;287:1021–1023.

    Article  CAS  Google Scholar 

  3. Colaco CB, Elkon KB. The lupus anticoagulant, a disease marker in ANA negative lupus, yet cross reactive with autoantibodies to ds DNA. Arthritis Rheum 1985;28:67–74.

    PubMed  CAS  Google Scholar 

  4. Emlen W, Niebur J-A, Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 1994;152:3685–3692.

    PubMed  CAS  Google Scholar 

  5. Georgescu L, Vakkalanka RK, Elkon KB, Crow MK. Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand. J Clin Invest 1997;100:2622–2633.

    PubMed  CAS  Google Scholar 

  6. Perniok A, Wedekind F, Herrmann M, Specker C, Schneider M. High levels of circulating early apoptotic peripheral blood mononuclear cells in systemic lupus erythematosus. Lupus 1998;7:113–118.

    Article  PubMed  CAS  Google Scholar 

  7. Ohsako S, Elkon KB. Increased caspase-like activity in freshly isolated lymphocytes from SLE patients. Arthritis Rheum 1998;41:S70.

    Google Scholar 

  8. Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 1998;41:1241–1250.

    Article  PubMed  CAS  Google Scholar 

  9. Rumore PM, Steinman CR. Endogenous circulating DNA in systemic lupus erythematosus, occurrence as multimeric complexes bound to histone. J Clin Invest 1990;86:69–74.

    PubMed  CAS  Google Scholar 

  10. Burlingame RW, Rubin RL, Balderas RS, Theofilopoulos AN. Genesis and evolution of anti-chromatin autoantibodies in murine lupus implicates T-dependent immunization and self antigen. J Clin Invest 1993;91:1687–1696.

    PubMed  CAS  Google Scholar 

  11. Amoura Z, Chabre H, Koutouzov S, et al. Nucleosome restricted antibodies are detected before antids DNA and/ or anti-histone antibodies in serum of MRL-Mp lpr/lpr and +/+ mice, and are present in kidney eluates of lupus mice with proteinuria. Arthritis Rheum 1994;37:1684–1688.

    PubMed  CAS  Google Scholar 

  12. Termaat RM, Assmann KJ, Dijkman HB, van Gompel F, Smeenk RJ, Berden JH. Anti-DNA antibodies can bind to the glomerulus via two distinct mechanisms. Kidney Int 1992;42:1363–1371.

    PubMed  CAS  Google Scholar 

  13. Kramers C, Hylkema MN, van Bruggen MCJ, et al. Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo. J Clin Invest 1994;94:568–577.

    PubMed  CAS  Google Scholar 

  14. Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994;179:1317–1330.

    Article  PubMed  CAS  Google Scholar 

  15. Price BE, Rauch J, Shia MA, et al. Antiphospholipid autoantibodies bind to apoptotic, but not viable, thymocytes in a beta2-glycoprotein I-dependent manner. J Immunol 1996;157:2201–2208.

    PubMed  CAS  Google Scholar 

  16. Bach R, Gentry R, Nemerson Y. Factor VII binding to tissue factor in reconstituted phospholipid vesicles: induction of cooperativity by phosphatidylserine. Biochemistry 1986;25:4007–4020.

    Article  PubMed  CAS  Google Scholar 

  17. Rosing J, van Rijn JL, Bevers EM, van Dieijen G, Comfurius P, Zwaal RF. The role of activated human platelets in prothrombin and factor X activation. Blood 1985;65:319–332.

    PubMed  CAS  Google Scholar 

  18. Vaishnaw AK, Orlinick JR, Chu JL, Krammer PH, Chao MV, Elkon KB. Molecular basis for the apoptotic defects in patients with CD95 (Fas/Apo-1) mutations. J Clin Invest 1999;103:355–363.

    PubMed  CAS  Google Scholar 

  19. Martin DA, Zheng L, Siegel RM, et al. Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia [in process citation]. Proc Natl Acad Sci U S A 1999;96:4552–4557.

    Article  PubMed  CAS  Google Scholar 

  20. Pittoni V, Sorice M, Circella A, et al. Specificity of antinuclear and antiphospholipid antibodies in sera of patients with autoimmune lymphoproliferative disease (ALD). Clin Exp Rheumatol 2003;21:377–385.

    PubMed  CAS  Google Scholar 

  21. Gharavi AE, Pierangeli SS, Harris EN. Viral origin of antiphospholipid antibodies: endothelial cell activation and thrombus enhancement by CMV peptide-induced APL antibodies. Immunobiology 2003;207:37–42.

    Article  PubMed  CAS  Google Scholar 

  22. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239–257.

    PubMed  CAS  Google Scholar 

  23. Zwaal RF, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997;89:1121–1132.

    PubMed  CAS  Google Scholar 

  24. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 1998;101:890–898.

    PubMed  CAS  Google Scholar 

  25. Zwaal RF, Comfurius P, Bevers EM. Scott syndrome, a bleeding disorder caused by defective scrambling of membrane phospholipids. Biochim Biophys Acta 2004;1636:119–128.

    PubMed  CAS  Google Scholar 

  26. Leist M, Single B, Castoldi AF, Kuhnle S, Nicotera P. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med 1997;185:1481–1486.

    Article  PubMed  CAS  Google Scholar 

  27. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998;391:43–50.

    Article  PubMed  CAS  Google Scholar 

  28. Casciola-Rosen LA, Anhalt GJ, Rosen A. DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis. J Exp Med 1995;182:1625–1634.

    Article  PubMed  CAS  Google Scholar 

  29. Hawiger D, Inaba K, Dorsett Y, et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 2001;194:769–779.

    Article  PubMed  CAS  Google Scholar 

  30. Somersan S, Bhardwaj N. Tethering and tickling: a new role for the phosphatidylserine receptor. J Cell Biol 2001;155:501–504.

    Article  PubMed  CAS  Google Scholar 

  31. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM. Exposure of phosphatidyl serine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992;148:2207–2216.

    PubMed  CAS  Google Scholar 

  32. Kagan VE, Gleiss B, Tyurina YY, et al. A role for oxidative stress in apoptosis: oxidation and externalization of phosphatidylserine is required for macrophage clearance of cells undergoing Fas-mediated apoptosis. J Immunol 2002;169:487–499.

    PubMed  CAS  Google Scholar 

  33. Savill J, Dransfield I, Gregory C, Haslett C. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol 2002;2:965–975.

    Article  PubMed  CAS  Google Scholar 

  34. Scott RS, McMahon EJ, Pop SM, et al. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 2001;411:207–211.

    Article  PubMed  CAS  Google Scholar 

  35. Hanayama R, Tanaka M, Miyasaka K, et al. Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science 2004;304:1147–1150.

    Article  PubMed  CAS  Google Scholar 

  36. Gershov D, Kim S, Brot N, Elkon KB. C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response. Implications for systemic autoimmunity. J Exp Med 2000;192:1353–1364.

    Article  PubMed  CAS  Google Scholar 

  37. Stach CM, Turnay X, Voll RE, et al. Treatment with annexin V increases immunogenicity of apoptotic human T-cells in Balb/c mice. Cell Death Differ 2000;7:911–915.

    Article  PubMed  CAS  Google Scholar 

  38. Mevorach D, Mascarenhas J, Gershov DA, Elkon KB. Complement-dependent clearance of apoptotic cells by human macrophages. J Exp Med 1998;188:2313–2320.

    Article  PubMed  CAS  Google Scholar 

  39. Botto M, Dell’Agnola C, Bygrave AE, et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 1998;19:56–59.

    PubMed  CAS  Google Scholar 

  40. Boes M, Schmidt T, Linkemann K, Beaudette BC, Marshak-Rothstein A, Chen J. Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. Proc Natl Acad Sci U S A 2000;97:1184–1189.

    Article  PubMed  CAS  Google Scholar 

  41. Ehrenstein MR, Cook HT, Neuberger MS. Deficiency in serum immunoglobulin (Ig)M predisposes to development of IgG autoantibodies. J Exp Med 2000;191:1253–1258.

    Article  PubMed  CAS  Google Scholar 

  42. Kim SJ, Gershov D, Ma X, Brot N, Elkon KB. I-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation. J Exp Med 2002;196:655–665.

    Article  PubMed  CAS  Google Scholar 

  43. Kim SJ, Gershov D, Ma X, Brot N, Elkon KB. Opsonization of apoptotic cells and its effect on macrophage and T cell immune responses. Ann N Y Acad Sci 2003;987:68–78.

    Article  PubMed  CAS  Google Scholar 

  44. Matsuura E, Igarashi Y, Yasuda T, Triplett DA, Koike T. Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 1994;179:457–462.

    Article  PubMed  CAS  Google Scholar 

  45. Mevorach D, Zhou J-L, Song X, Elkon KB. Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med 1998;188:387–392.

    Article  PubMed  CAS  Google Scholar 

  46. Asano K, Miwa M, Miwa K, et al. Masking of phosphatidylserine inhibits apoptotic cell engulfment and induces autoantibody production in mice. J Exp Med 2004;200:459–67.

    Article  PubMed  CAS  Google Scholar 

  47. Elkon KB. Apoptosis in SLE-too little or too much? Clin Exp Rheum 1994;12:553–559.

    CAS  Google Scholar 

  48. Wu J, Wilson J, He J, Xiang L, Schur PH, Mountz JD. Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J Clin Invest 1996;98:1107–1113.

    Article  PubMed  CAS  Google Scholar 

  49. Vaishnaw AK, Toubi E, Ohsako S, et al. Both quantitative and qualitative apoptotic defects are associated with the clinical spectrum of disease, including systemic lupus erythematosus in humans with Fas (APO-1/CD95) mutations. Arthritis Rheum 1999;42:1833–1842.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine and Immunology, University of Washington, Seattle, WA, USA

    Keith B. Elkon MD

  2. Department of Medicine, University of Washington, Seattle, WA, USA

    Neelufar Mozaffarian MD, PhD & Natalia Tishkevich MD

Authors
  1. Keith B. Elkon MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Neelufar Mozaffarian MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Natalia Tishkevich MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Lupus Research Unit, St Thomas’ Hospital, London, UK

    M. A. Khamashta MD, FRCP, PhD (Deputy Head) (Deputy Head)

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag London Limited

About this chapter

Cite this chapter

Elkon, K.B., Mozaffarian, N., Tishkevich, N. (2006). Apoptosis and Antiphospholipid Antibodies. In: Khamashta, M.A. (eds) Hughes Syndrome. Springer, London. https://doi.org/10.1007/1-84628-009-5_39

Download citation

  • DOI: https://doi.org/10.1007/1-84628-009-5_39

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-85233-873-2

  • Online ISBN: 978-1-84628-009-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation